HEARTFLOW INC (HTFL) — insider trading
Health Care · NASDAQ
HEARTFLOW INC (HTFL) has 85 reported SEC Form 4 insider transactions in our data, including 27 open-market sales among the most recent 85 (latest 2026-09-18).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 850 | — | $0 | Form 4 |
| 2026-09-18 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 12,329 | — | $0 | Form 4 |
| 2026-09-18 | Rogers Campbell | Officer (Chief Medical Officer) | Open-market sale | 19,682 | $50.15 | $987.1K | Form 4 |
| 2026-09-18 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion | 850 | $2.22 | $1.9K | Form 4 |
| 2026-09-18 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion | 12,329 | $8.33 | $102.7K | Form 4 |
| 2026-09-18 | Verghese Vikram | Officer (Chief Financial Officer) | Open-market sale | 16,766 | $50.75 | $850.9K | Form 4 |
| 2026-09-17 | Verghese Vikram | Officer (Chief Financial Officer) | Open-market sale | 7,579 | $50.11 | $379.8K | Form 4 |
| 2026-09-15 | Verghese Vikram | Officer (Chief Financial Officer) | Open-market sale | 668 | $50.01 | $33.4K | Form 4 |
| 2026-09-14 | Verghese Vikram | Officer (Chief Financial Officer) | Open-market sale | 4,593 | $50.24 | $230.7K | Form 4 |
| 2026-09-11 | Verghese Vikram | Officer (Chief Financial Officer) | Open-market sale | 29,714 | $50.06 | $1.49M | Form 4 |
| 2026-09-11 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Open-market sale | 3,890 | $50.00 | $194.5K | Form 4 |
| 2026-09-10 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Open-market sale | 35,010 | $46.42 | $1.63M | Form 4 |
| 2026-09-08 | Verghese Vikram | Officer (Chief Financial Officer) | Open-market sale | 6,640 | $50.03 | $332.2K | Form 4 |
| 2026-09-03 | Verghese Vikram | Officer (Chief Financial Officer) | Open-market sale | 27,540 | $49.69 | $1.37M | Form 4 |
| 2026-09-02 | Verghese Vikram | Officer (Chief Financial Officer) | Open-market sale | 5,876 | $50.60 | $297.3K | Form 4 |
| 2026-08-21 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Open-market sale | 27,230 | $50.00 | $1.36M | Form 4 |
| 2026-08-18 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Open-market sale | 32,676 | $45.00 | $1.47M | Form 4 |
| 2026-08-17 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 9,219 | — | $0 | Form 4 |
| 2026-08-17 | Rogers Campbell | Officer (Chief Medical Officer) | Open-market sale | 9,219 | $41.23 | $380.1K | Form 4 |
| 2026-08-17 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion | 9,219 | $19.00 | $175.2K | Form 4 |
| 2026-08-14 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Open-market sale | 15,560 | $39.06 | $607.8K | Form 4 |
| 2026-08-10 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Open-market sale | 22,562 | $28.31 | $638.7K | Form 4 |
| 2026-08-07 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 1,904 | $28.82 | $54.9K | Form 4 |
| 2026-08-07 | Rogers Campbell | Officer (Chief Medical Officer) | Shares withheld for taxes / exercise cost | 637 | $28.82 | $18.4K | Form 4 |
| 2026-08-07 | Verghese Vikram | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 473 | $28.82 | $13.6K | Form 4 |
| 2026-08-07 | Jones Marie L. | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 82 | $28.82 | $2.4K | Form 4 |
| 2026-08-06 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 5,847 | $27.19 | $159.0K | Form 4 |
| 2026-08-06 | Rogers Campbell | Officer (Chief Medical Officer) | Shares withheld for taxes / exercise cost | 1,635 | $27.19 | $44.5K | Form 4 |
| 2026-08-06 | Verghese Vikram | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,537 | $27.19 | $41.8K | Form 4 |
| 2026-08-06 | Jones Marie L. | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 486 | $27.19 | $13.2K | Form 4 |
| 2026-07-30 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 9,737 | — | $0 | Form 4 |
| 2026-07-30 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 2,789 | — | $0 | Form 4 |
| 2026-07-30 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 18,694 | — | $0 | Form 4 |
| 2026-07-30 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 9,737 | $9.58 | $93.3K | Form 4 |
| 2026-07-30 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 18,694 | $2.22 | $41.5K | Form 4 |
| 2026-07-30 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 2,789 | $8.33 | $23.2K | Form 4 |
| 2026-07-27 | Verghese Vikram | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 22,522 | — | $0 | Form 4 |
| 2026-07-27 | Verghese Vikram | Officer (Chief Financial Officer) | Option exercise / conversion | 22,522 | $2.22 | $50.0K | Form 4 |
| 2026-07-24 | Lightcap Jeffrey C | Director | Option exercise / conversion (derivative) | 47,420 | — | $0 | Form 4 |
| 2026-07-24 | Lightcap Jeffrey C | Director | Option exercise / conversion | 47,420 | $19.00 | $901.0K | Form 4 |
| 2026-07-22 | BARABE TIMOTHY C | Director | Option exercise / conversion (derivative) | 3,710 | — | $0 | Form 4 |
| 2026-07-22 | BARABE TIMOTHY C | Director | Option exercise / conversion | 3,710 | $19.00 | $70.5K | Form 4 |
| 2026-07-21 | Verghese Vikram | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 22,522 | — | $0 | Form 4 |
| 2026-07-21 | Verghese Vikram | Officer (Chief Financial Officer) | Option exercise / conversion | 22,522 | $2.22 | $50.0K | Form 4 |
| 2026-07-17 | BARABE TIMOTHY C | Director | Option exercise / conversion (derivative) | 5,000 | — | $0 | Form 4 |
| 2026-07-17 | BARABE TIMOTHY C | Director | Option exercise / conversion | 5,000 | $19.00 | $95.0K | Form 4 |
| 2026-07-15 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 9,219 | — | $0 | Form 4 |
| 2026-07-15 | Rogers Campbell | Officer (Chief Medical Officer) | Open-market sale | 9,219 | $25.72 | $237.1K | Form 4 |
| 2026-07-15 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion | 9,219 | $19.00 | $175.2K | Form 4 |
| 2026-07-10 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Open-market sale | 22,562 | $27.75 | $626.1K | Form 4 |
| 2026-07-08 | WELDON WILLIAM C | Director | Option exercise / conversion (derivative) | 17,123 | — | $0 | Form 4 |
| 2026-07-08 | WELDON WILLIAM C | Director | Option exercise / conversion (derivative) | 17,123 | — | $0 | Form 4 |
| 2026-07-08 | WELDON WILLIAM C | Director | Option exercise / conversion (derivative) | 17,123 | — | $0 | Form 4 |
| 2026-07-08 | WELDON WILLIAM C | Director | Option exercise / conversion | 17,123 | $8.33 | $142.6K | Form 4 |
| 2026-07-08 | WELDON WILLIAM C | Director | Option exercise / conversion | 17,123 | $8.33 | $142.6K | Form 4 |
| 2026-07-08 | WELDON WILLIAM C | Director | Option exercise / conversion | 17,123 | $8.33 | $142.6K | Form 4 |
| 2026-06-24 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Open-market sale | 38,900 | $35.00 | $1.36M | Form 4 |
| 2026-06-16 | Tansey Casey M | Director | Grant / award / vesting (derivative) | 16,075 | $32.05 | $515.2K | Form 4 |
| 2026-06-16 | Riley Wayne Joseph | Director | Grant / award / vesting (derivative) | 16,075 | $32.05 | $515.2K | Form 4 |
| 2026-06-16 | Lightcap Jeffrey C | Director | Grant / award / vesting (derivative) | 16,075 | $32.05 | $515.2K | Form 4 |
| 2026-06-16 | Cullivan Julie A | Director | Grant / award / vesting (derivative) | 16,075 | $32.05 | $515.2K | Form 4 |
| 2026-06-16 | BARABE TIMOTHY C | Director | Grant / award / vesting (derivative) | 16,075 | $32.05 | $515.2K | Form 4 |
| 2026-06-16 | WELDON WILLIAM C | Director | Grant / award / vesting (derivative) | 16,075 | $32.05 | $515.2K | Form 4 |
| 2026-06-15 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 10,000 | — | $0 | Form 4 |
| 2026-06-15 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion | 10,000 | $2.22 | $22.2K | Form 4 |
| 2026-06-10 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Open-market sale | 22,562 | $28.50 | $643.0K | Form 4 |
| 2026-05-18 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 9,219 | — | $0 | Form 4 |
| 2026-05-18 | Rogers Campbell | Officer (Chief Medical Officer) | Open-market sale | 9,219 | $28.34 | $261.3K | Form 4 |
| 2026-05-18 | Rogers Campbell | Officer (Chief Medical Officer) | Option exercise / conversion | 9,219 | $19.00 | $175.2K | Form 4 |
| 2026-05-11 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Open-market sale | 22,562 | $29.12 | $657.0K | Form 4 |
| 2026-05-07 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 1,904 | $29.98 | $57.1K | Form 4 |
| 2026-05-07 | Verghese Vikram | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 473 | $29.98 | $14.2K | Form 4 |
| 2026-05-07 | Rogers Campbell | Officer (Chief Medical Officer) | Shares withheld for taxes / exercise cost | 637 | $29.98 | $19.1K | Form 4 |
| 2026-05-07 | Jones Marie L. | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 82 | $29.98 | $2.5K | Form 4 |
| 2026-05-06 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 5,300 | $30.29 | $160.5K | Form 4 |
| 2026-05-06 | Verghese Vikram | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,536 | $30.29 | $46.5K | Form 4 |
| 2026-05-06 | Rogers Campbell | Officer (Chief Medical Officer) | Shares withheld for taxes / exercise cost | 1,634 | $30.29 | $49.5K | Form 4 |
| 2026-05-06 | Jones Marie L. | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 485 | $30.29 | $14.7K | Form 4 |
| 2026-04-30 | Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences III General Partner, LLC; Bain Capital Life Sciences Fund III, L.P.; BCLS Fund III Investments GP, LLC; BCLS Fund III Investments, LP | 10% owner | Open-market sale | 56,224 | $30.05 | $1.69M | Form 4 |
| 2026-04-30 | Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences III General Partner, LLC; Bain Capital Life Sciences Fund III, L.P.; BCLS Fund III Investments GP, LLC; BCLS Fund III Investments, LP | 10% owner | Open-market sale | 892,533 | $29.18 | $26.04M | Form 4 |
| 2026-04-29 | Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences III General Partner, LLC; Bain Capital Life Sciences Fund III, L.P.; BCLS Fund III Investments GP, LLC; BCLS Fund III Investments, LP | 10% owner | Open-market sale | 797,133 | $29.37 | $23.41M | Form 4 |
| 2026-04-28 | Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences III General Partner, LLC; Bain Capital Life Sciences Fund III, L.P.; BCLS Fund III Investments GP, LLC; BCLS Fund III Investments, LP | 10% owner | Open-market sale | 254,110 | $30.51 | $7.75M | Form 4 |
| 2026-04-10 | Farquhar John C.M. | Director, Officer (Chief Executive Officer) | Open-market sale | 22,562 | $26.72 | $602.9K | Form 4 |
| 2026-03-06 | Verghese Vikram | Officer (Chief Financial Officer) | Grant / award / vesting | 671 | $16.15 | $10.8K | Form 4 |
| 2026-03-06 | Jones Marie L. | Officer (Chief Accounting Officer) | Grant / award / vesting | 1,661 | $16.15 | $26.8K | Form 4 |
Ask the chat about HTFL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: HEARTFLOW INC (HTFL).
Last updated 2026-09-18 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.